Published in J Clin Microbiol on January 01, 1981
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J Bacteriol (1982) 3.82
Cloning and expression of an afimbrial adhesin (AFA-I) responsible for P blood group-independent, mannose-resistant hemagglutination from a pyelonephritic Escherichia coli strain. Infect Immun (1984) 3.75
Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol (1989) 3.70
Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev (1984) 3.66
Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol (1982) 3.28
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest (1985) 2.97
Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli O6 strain 536. J Bacteriol (1986) 2.65
Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli O6 strain. J Bacteriol (1983) 2.61
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun (1983) 2.60
Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect Immun (1981) 2.59
Escherichia coli in extra-intestinal infections. J Hyg (Lond) (1985) 2.51
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun (1983) 2.26
Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun (1987) 2.25
Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med (2012) 2.20
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol (1987) 2.07
Relationship between plasmid and chromosomal hemolysin determinants of Escherichia coli. J Bacteriol (1983) 1.87
Cloning of a phosphate-regulated hemolysin gene (phospholipase C) from Pseudomonas aeruginosa. J Bacteriol (1982) 1.76
Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest (1990) 1.64
Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med (1989) 1.60
Cloning, and expression in Escherichia coli K-12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa. J Bacteriol (1983) 1.58
Gene block encoding production of cytotoxic necrotizing factor 1 and hemolysin in Escherichia coli isolates from extraintestinal infections. Infect Immun (1992) 1.45
Toxin production and haemagglutination in strains of Escherichia coli from diarrhoea in Brescia, Italy. J Hyg (Lond) (1985) 1.37
Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes. J Exp Med (1985) 1.30
Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect Immun (1989) 1.27
Isolation, purification, and partial characterization of type V-A hemagglutinin from Escherichia coli GV-12, O1:H-. J Bacteriol (1982) 1.11
Isolation and characterization of Escherichia coli pili from diverse clinical sources. Infect Immun (1983) 1.10
Hemagglutination by Bordetella bronchiseptica. J Clin Microbiol (1982) 1.03
Increased frequency of ColV plasmids and mannose-resistant hemagglutinating activity in an Escherichia coli K1 population. J Clin Microbiol (1983) 0.92
Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis. Infect Immun (2000) 0.92
Relationship between cytotoxic necrotizing factor production and serotype in hemolytic Escherichia coli. J Clin Microbiol (1989) 0.91
Serological heterogeneity among fimbrial antigens causing mannose-resistant hemagglutination by uropathogenic Escherichia coli. Infect Immun (1982) 0.89
Antigenic heterogeneity of haemagglutination type VI fimbriae produced by Escherichia coli isolated from patients with bacteremia. J Clin Microbiol (1982) 0.89
Immune response to Escherichia coli alpha-hemolysin in patients. J Clin Microbiol (1988) 0.87
In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants. Infect Immun (1996) 0.84
Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J Med Food (2011) 0.81
Correlation between esterase electrophoretic polymorphism and virulence-associated traits in extra-intestinal invasive strains of Escherichia coli. Epidemiol Infect (1994) 0.78
Role of pore-forming toxins in neonatal sepsis. Clin Dev Immunol (2013) 0.78
Evaluation of Virulence Factors and Antibiotic Sensitivity Pattern of Escherichia Coli Isolated from Extraintestinal Infections. Cureus (2016) 0.75
Production of a bacteriolysin by a hemolytic Escherichia coli strain. Infect Immun (1983) 0.75
Comparison of Hemagglutination and Hemolytic Activity of Various Bacterial Clinical Isolates Against Different Human Blood Groups. Cureus (2016) 0.75
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89
Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates. Infect Immun (1978) 7.28
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15
Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
The haemolysins of Escherichia coli. J Pathol Bacteriol (1963) 3.99
Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol (1975) 3.54
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis (1973) 3.02
Frequency of E. coli K antigens in urinary-tract infections in children. Lancet (1977) 2.89
Antigens of the type-1 fimbriae of salmonellae and other enterobacteria. J Med Microbiol (1969) 2.82
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Serological grouping of Escherichia coli. Study in urinary tract infection. Arch Intern Med (1962) 2.61
Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J Pediatr (1978) 2.60
HOST-PARASITE INTERACTION IN PATIENTS WITH INFECTIONS DUE TO ESCHERICHIA COLI. I. THE SEROGROUPING OF E. COLI FROM INTESTINAL AND EXTRAINTESTINAL SOURCES. J Clin Invest (1964) 2.42
K antigens of Escherichia coli and renal involvement in urinary-tract infections. Lancet (1971) 2.40
BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY. N Engl J Med (1965) 2.39
Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. J Med Microbiol (1980) 2.28
Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections. Lancet (1978) 2.25
Escherichia coli O:H serotypes isolated from human blood. Prevalence of the K1 antigen with technical details of O and H antigenic determination. Acta Pathol Microbiol Scand Suppl (1975) 2.05
Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system. Am J Med Sci (1970) 2.05
Escherichia coli serotypes and renal involvement in urinary-tract infection. Lancet (1971) 2.04
In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infect Immun (1980) 1.98
Virulence factors of the bacterial cell surface. J Infect Dis (1978) 1.95
Hemagglutination by Escherichia coli in septicemia and urinary tract infections. J Clin Microbiol (1979) 1.55
Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors. J Clin Invest (1976) 1.19
Neonatal meningitis due of Escherichia coli K1. J Infect Dis (1977) 1.18
Adhesive properties of Escherichia coli from urinary-tract infections. J Med Microbiol (1980) 1.07
Escherichia coli K antigen. Zentralbl Bakteriol Orig A (1979) 1.00
Adhesion to a human cell line by Escherichia coli strains isolated during urinary tract infections. J Clin Microbiol (1979) 0.89
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol (1982) 10.32
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1987) 8.19
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J (1987) 6.26
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63
Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab (1982) 5.60
Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol (1990) 5.41
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and "Campylobacter laridis". J Clin Microbiol (1984) 5.01
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet (1991) 4.76
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet (1983) 4.70
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis (1987) 4.54
Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol (1988) 4.47
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
BVA policy on farm animal welfare. Vet Rec (1991) 4.25
Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol (1994) 4.08
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96
Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents. Antimicrob Agents Chemother (1977) 3.91
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet (1992) 3.85
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57
Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol (1987) 3.53
In vitro production of choleragen and vascular permeability factor by Vibrio cholerae. J Bacteriol (1968) 3.52
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol (1992) 3.41
A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog (1988) 3.31
Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol (1987) 3.28
Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis (1972) 3.28
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog (1988) 3.24
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob Agents Chemother (1987) 3.06
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol Infect (1990) 3.02
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis (1986) 2.92
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. Antimicrob Agents Chemother (1973) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1991) 2.78
Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature (1990) 2.72
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70